All posts tagged NuVasive
NuVasive hit with FDA warning letter over spine device
On March 12, the FDA issued a warning letter to NuVasive for selling Affix Spinous Process Plate systems for uses not approved by the device’s 510(k) clearance. The Affix system is approved to clamp spine grafts in place during surgery. …
NuVasive Shares Jump As 1Q Shows Share Gains In Spinal Market
By Anjali Athavaley Of DOW JONES NEWSWIRESNEW YORK (Dow Jones)--NuVasive Inc.'s (NUVA) first-quarter results indicated that the medical-device maker continues to gain share of the
NuVasive (NUVA) Shares Given New $15.00 Price Target by Kaufman Brothers Analysts
Equities research analysts at Kaufman Brothers lowered their price target on shares of NuVasive (NASDAQ: NUVA) from $21.00 to $15.00 in a research issued note to investors on Tuesday.
JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT
JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT
Click Here for the Entire Article From Canaccord
NuVasive Announces Jury Verdict in Patent Case
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that a jury in the U.S.
Jury Awards Medtronic $101 Million In Patent Suit Against NuVasive
MEMPHIS, TENN. – Sept. 20, 2011 – Medtronic, Inc. (NYSE: MDT) announced today that a jury in the United States District Court of the Southern District of California in San
NuVasive to Offer $325 Million Convertible Senior Notes Due 2017
SAN DIEGO, CA, Jun 21, 2011 (MARKETWIRE via COMTEX) -- NuVasive, Inc. NUVA -3.71% (the "Company"), a medical device company focused on developing minimally disruptive surgical products and procedures
Judge nixes Medtronic, NuVasive motions in patent infringement case
A federal judge in California dealt blows to both sides in a patent infringement dispute over spinal implant technology between several Medtronic Inc. (NYSE:
NuVasive and AlloSource Announce Licensing Agreement
SAN DIEGO, CA -- (Marketwire) -- 02/10/11 -- NuVasive, Inc. (NASDAQ: NUVA) and AlloSource, partners in the cellular allograft market for use in orthopedic surgical applications, announced today
NuVasive Announces Insurance Coverage Policy Change Regarding XLIF(R) Procedure
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that both CIGNA and Humana recently
NuVasive Loses Brand-Name Case To Neurovision, Vows Appeal
* Jury awards $60 mln as damages to plaintiff * NuVasive intends to appeal verdict Oct 27 (Reuters) - A U.S. district court ruled against medical device maker NuVasive Inc
Advanced BioHealing Appoints Kevin C. O’Boyle as Chief Financial Officer
WESTPORT, Conn., Dec. 10, 2010 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative medicine, today announced the
Competition To Increase in the $740 Million Minimally Invasive Spinal Fusion Market
TORONTO, Dec. 8, 2010 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, competition will intensify in the $740 million minimally invasive spinal fusion market
NuVasive Poised For Strong Results
Nuvasive Inc. (NYSE: NUVA) plans on holding an analyst meeting on September 14. According to Jefferies, while there may be doubt in the company's ability to continue its